Efficacy and safety of vancomycin versus 13 alternatives in MRSA-confirmed skin and soft tissue infections: a meta-analysis of 39 randomized controlled trials. [PDF]
Purja S, Elghanam Y, Kim E.
europepmc +1 more source
ORItavancin as a therapeutic regimen for Cardiac Implantable Electronic Devices infections with multidrug-resistant Gram-positive cocci (ORI-4-CIEDi) pilot study: rationale and design. [PDF]
Łoboda D +10 more
europepmc +1 more source
Treatment of chronic rhinosinusitis and acute recurring rhinosinusitis with omadacycline: A case series. [PDF]
Pugliese A.
europepmc +1 more source
Delafloxacin: what does a new fluoroquinolone offer? [PDF]
Cercenado E, Murillo O.
europepmc +1 more source
A Systematic Review of Health-Related Quality-of-Life Measurement in Patients With Acute Bacterial Skin and Skin Structure Infections. [PDF]
Sutton KN +12 more
europepmc +1 more source
Delafloxacin Resistance and MIC-Distribution in Ciprofloxacin-Resistant Enterobacterales: A Retrospective Evaluation of Minimum Inhibitory Concentrations. [PDF]
Forstner P +8 more
europepmc +1 more source
Population pharmacokinetics of dalbavancin: external validation, model averaging, and implications for precision dosing in prolonged therapy. [PDF]
Sayadi H +9 more
europepmc +1 more source
Impact of obesity on clinical outcomes in patients treated with ceftobiprole: results from Phase 3 clinical trials. [PDF]
Holland TL +8 more
europepmc +1 more source
A Comparative Review of the Pharmacology of Dalbavancin and Oritavancin for Gram-Positive Infections: Birds of a Feather or Apples and Oranges? [PDF]
Hussein M +11 more
europepmc +1 more source
A Phase 3 Study of the Safety and Efficacy of Tedizolid Phosphate in Patients <12 Years of Age With Acute Bacterial Skin and Skin Structure Infections. [PDF]
Mngqibisa R +9 more
europepmc +1 more source

